Ceftizoxime

Y. Tsai, Pharm.D., Kathryn Dzintars, Pharm.D., BCPS

INDICATIONS

FDA

No longer marketed in the U.S. as of 2007; archived U.S. labeling was last updated in 2007 and should not be interpreted as current preferred therapy.

Lower respiratory tract infections
Urinary tract infections
Gonorrhea including uncomplicated cervical and urethral gonorrhea
Pelvic inflammatory disease caused by N. gonorrhoeae, E. coli or S. agalactiae
Intra-abdominal infections
Septicemia caused by MSSA, E. coli,Bacteroides spp. including B. fragilis, Klebsiella spp. and Serratia spp.
Skin and skin-structure infections (not MRSA)
Bone and joint infections
Meningitis caused by H. influenzae

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.